Alkem Laboratories Limited — Call Transcript 2026

Jan 23, 2026

==> picture [595 x 115] intentionally omitted <==

23[rd] January, 2026

To,
The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001. Scrip Code: 539523	National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai 400 051. Scrip Symbol: ALKEM

Sub: Intimation of Conference Call on Q3FY26 and 9MFY26 financial results

Dear Sir(s) / Madam,

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY26 and 9MFY26 financial results will be held on Friday, February 13, 2026 at 04.00 p.m.

Please find attached herewith the conference call details.

Kindly take note of the same.

Sincerely, For Alkem Laboratories Limited

Digitally signed MANISH by MANISH NARANG NARANG Date: 2026.01.23 17:54:15 +05'30'

Manish Narang

President – Legal, Company Secretary & Compliance Officer

==> picture [110 x 71] intentionally omitted <==

==> picture [15 x 10] intentionally omitted <==

==> picture [34 x 10] intentionally omitted <==

==> picture [34 x 10] intentionally omitted <==

==> picture [33 x 9] intentionally omitted <==

==> picture [10 x 9] intentionally omitted <==

==> picture [8 x 9] intentionally omitted <==

==> picture [9 x 9] intentionally omitted <==

==> picture [220 x 31] intentionally omitted <==

==> picture [128 x 19] intentionally omitted <==

==> picture [120 x 7] intentionally omitted <==

==> picture [75 x 16] intentionally omitted <==

==> picture [55 x 16] intentionally omitted <==

==> picture [171 x 16] intentionally omitted <==

==> picture [69 x 16] intentionally omitted <==

==> picture [63 x 16] intentionally omitted <==

==> picture [30 x 16] intentionally omitted <==

Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Friday, February 13, 2026, from 4:00 pm to 5:00 pm IST to discuss its Q3 and 9MFY26 financial results. The call will follow the announcement of the Company’s Q3 and 9MFY26 financial results on Friday, February 13, 2026.

==> picture [186 x 15] intentionally omitted <==

==> picture [142 x 15] intentionally omitted <==

Dr. Vikas Gupta – CEO

Mr. Nitin Agrawal – CFO

==> picture [45 x 16] intentionally omitted <==

==> picture [43 x 16] intentionally omitted <==

==> picture [64 x 16] intentionally omitted <==

==> picture [28 x 16] intentionally omitted <==

==> picture [25 x 16] intentionally omitted <==

==> picture [33 x 16] intentionally omitted <==

==> picture [33 x 16] intentionally omitted <==

==> picture [255 x 15] intentionally omitted <==

==> picture [35 x 15] intentionally omitted <==

4:00 pm IST (GMT + 5:30) on Friday, February 13, 2026.

==> picture [45 x 15] intentionally omitted <==

==> picture [406 x 136] intentionally omitted <==

----- Start of picture text -----

+91 22 6280 1149 / +91 22 7115 8050
1 866 746 2133 0 808 101 1573
800 101 2045 800 964 448
----- End of picture text -----

==> picture [165 x 16] intentionally omitted <==

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5695 698&linkSecurityString=2d7a78d3cc

==> picture [371 x 16] intentionally omitted <==

==> picture [106 x 15] intentionally omitted <==

Investor Relations / Media Alkem Laboratories Ltd. Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: purvi.shah@alkem.com/ isha.trivedi@alkem.com

==> picture [75 x 15] intentionally omitted <==

Institutional Research Analyst - Healthcare Motilal Oswal Securities Ltd. Tel.: +91 22 6129 1536 / +91 82911 38039 E-mail: Tushar.Manudhane@motilaloswal.com